SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001005477-00-007467
Filing Date
2000-10-31
Accepted
2000-10-31 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 ADDITIONAL PROXY MATERIAL 0001.txt DEFA14A 4380
  Complete submission text file 0001005477-00-007467.txt   6215
Mailing Address 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address 175 CROSSING BLVD BIOTECHNOLOGY RESEARCH PARK FRAMINGHAM MA 01702 5087975777
AQUILA BIOPHARMACEUTICALS INC (Filer) CIK: 0000704292 (see all company filings)

IRS No.: 043307818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-12081 | Film No.: 749625
SIC: 2835 In Vitro & In Vivo Diagnostic Substances